Collectively, these data indicated that YXS is an effective treatment which enhanced heart function and decreased myocardial damage by restoring Trx2 and inhibiting JNK and p38 activation in ischemia-induced HF. This evidence concerns the gene TXN2 and hydrops fetalis.